Howard W. Robin

CIK: 0001206869

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)26 (83.9%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (16.1%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NKTR

NEKTAR THERAPEUTICS

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (31 total)

NKTR
NEKTAR THERAPEUTICS
Aug 18, 2026
Sale(S)
Direct
418 shares at avg. $71.98$30K
NKTR
NEKTAR THERAPEUTICS
Jul 24, 2026
Award(A)
Stock Option
Direct
57.2K shares-
NKTR
NEKTAR THERAPEUTICS
Jun 17, 2026
Sale(S)
Direct
4.5K shares at avg. $61.65$277K
NKTR
NEKTAR THERAPEUTICS
Jun 17, 2026
Sale(S)
Direct
5.5K shares at avg. $60.81$334K
NKTR
NEKTAR THERAPEUTICS
Jun 16, 2026
Sale(S)
Direct
5.3K shares at avg. $59.97$318K
NKTR
NEKTAR THERAPEUTICS
Jun 16, 2026
Sale(S)
Direct
4.7K shares at avg. $60.71$285K
NKTR
NEKTAR THERAPEUTICS
May 19, 2026
Sale(S)
Direct
444 shares at avg. $65.51$29K
NKTR
NEKTAR THERAPEUTICS
Feb 18, 2026
Sale(S)
Direct
423 shares at avg. $73.00$31K
NKTR
NEKTAR THERAPEUTICS
Dec 22, 2025
Award(A)
Direct
21.7K shares-
NKTR
NEKTAR THERAPEUTICS
Nov 25, 2025
Sale(S)
Direct
2.2K shares at avg. $54.28$120K
NKTR
NEKTAR THERAPEUTICS
Nov 21, 2025
Award(A)
Direct
7.1K shares-
NKTR
NEKTAR THERAPEUTICS
Sep 9, 2025
Sale(S)
Direct
1.2K shares at avg. $46.41$56K
NKTR
NEKTAR THERAPEUTICS
Sep 9, 2025
Sale(S)
Direct
2.2K shares at avg. $47.49$102K
NKTR
NEKTAR THERAPEUTICS
Sep 9, 2025
Sale(S)
Direct
1.2K shares at avg. $48.18$58K
NKTR
NEKTAR THERAPEUTICS
Sep 9, 2025
Sale(S)
Direct
2.1K shares at avg. $45.16$95K
NKTR
NEKTAR THERAPEUTICS
Sep 5, 2025
Sale(S)
Direct
1.1K shares at avg. $39.89$45K
NKTR
NEKTAR THERAPEUTICS
Sep 5, 2025
Sale(S)
Direct
2.2K shares at avg. $38.82$86K
NKTR
NEKTAR THERAPEUTICS
Sep 5, 2025
Sale(S)
Direct
3.3K shares at avg. $37.87$125K
NKTR
NEKTAR THERAPEUTICS
Sep 4, 2025
Sale(S)
Direct
1.1K shares at avg. $35.80$41K
NKTR
NEKTAR THERAPEUTICS
Sep 4, 2025
Sale(S)
Direct
613 shares at avg. $34.40$21K
NKTR
NEKTAR THERAPEUTICS
Sep 4, 2025
Sale(S)
Direct
1.5K shares at avg. $33.54$50K
NKTR
NEKTAR THERAPEUTICS
Sep 4, 2025
Sale(S)
Direct
1.9K shares at avg. $32.37$62K
NKTR
NEKTAR THERAPEUTICS
Sep 2, 2025
Sale(S)
Direct
1.5K shares at avg. $30.16$45K
NKTR
NEKTAR THERAPEUTICS
Aug 19, 2025
Award(A)
Stock Option
Direct
86.7K shares-
NKTR
NEKTAR THERAPEUTICS
Aug 19, 2025
Sale(S)
Direct
1.6K shares at avg. $26.59$42K

		Type	Shares	Price		Ownership
Aug 18, 2026	NKTR NEKTAR THERAPEUTICS	Sale(S)	418	$71.98	$30,088	Direct
Jul 24, 2026	NKTR NEKTAR THERAPEUTICS	Award(A) Stock Option	57,200	-	-	Direct
Jun 17, 2026	NKTR NEKTAR THERAPEUTICS	Sale(S)	4,500	$61.65	$277,425	Direct
Jun 17, 2026	NKTR NEKTAR THERAPEUTICS	Sale(S)	5,500	$60.81	$334,455	Direct
Jun 16, 2026	NKTR NEKTAR THERAPEUTICS	Sale(S)	5,303	$59.97	$318,021	Direct
Jun 16, 2026	NKTR NEKTAR THERAPEUTICS	Sale(S)	4,697	$60.71	$285,155	Direct
May 19, 2026	NKTR NEKTAR THERAPEUTICS	Sale(S)	444	$65.51	$29,086	Direct
Feb 18, 2026	NKTR NEKTAR THERAPEUTICS	Sale(S)	423	$73.00	$30,879	Direct
Dec 22, 2025	NKTR NEKTAR THERAPEUTICS	Award(A)	21,667	-	-	Direct
Nov 25, 2025	NKTR NEKTAR THERAPEUTICS	Sale(S)	2,207	$54.28	$119,796	Direct
Nov 21, 2025	NKTR NEKTAR THERAPEUTICS	Award(A)	7,110	-	-	Direct
Sep 9, 2025	NKTR NEKTAR THERAPEUTICS	Sale(S)	1,200	$46.41	$55,692	Direct
Sep 9, 2025	NKTR NEKTAR THERAPEUTICS	Sale(S)	2,156	$47.49	$102,388	Direct
Sep 9, 2025	NKTR NEKTAR THERAPEUTICS	Sale(S)	1,210	$48.18	$58,298	Direct
Sep 9, 2025	NKTR NEKTAR THERAPEUTICS	Sale(S)	2,100	$45.16	$94,836	Direct
Sep 5, 2025	NKTR NEKTAR THERAPEUTICS	Sale(S)	1,136	$39.89	$45,315	Direct
Sep 5, 2025	NKTR NEKTAR THERAPEUTICS	Sale(S)	2,226	$38.82	$86,413	Direct
Sep 5, 2025	NKTR NEKTAR THERAPEUTICS	Sale(S)	3,304	$37.87	$125,122	Direct
Sep 4, 2025	NKTR NEKTAR THERAPEUTICS	Sale(S)	1,134	$35.80	$40,597	Direct
Sep 4, 2025	NKTR NEKTAR THERAPEUTICS	Sale(S)	613	$34.40	$21,087	Direct
Sep 4, 2025	NKTR NEKTAR THERAPEUTICS	Sale(S)	1,496	$33.54	$50,176	Direct
Sep 4, 2025	NKTR NEKTAR THERAPEUTICS	Sale(S)	1,923	$32.37	$62,248	Direct
Sep 2, 2025	NKTR NEKTAR THERAPEUTICS	Sale(S)	1,500	$30.16	$45,240	Direct
Aug 19, 2025	NKTR NEKTAR THERAPEUTICS	Award(A) Stock Option	86,666	-	-	Direct
Aug 19, 2025	NKTR NEKTAR THERAPEUTICS	Sale(S)	1,573	$26.59	$41,826	Direct

1-25 of 31 transactions

About ROBIN HOWARD W

ROBIN HOWARD W (SEC CIK 0001206869) files insider reports with the SEC as President & CEO of NEKTAR THERAPEUTICS (NKTR).

Signal8 holds 16 ownership filings by ROBIN HOWARD W, all Form 4s, filed between Nov 20, 2024 and Aug 20, 2026. Those filings report 31 transactions, from Nov 19, 2024 to Aug 18, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on ROBIN HOWARD W's filings is in SAN FRANCISCO, CA.

Recent filings by ROBIN HOWARD W

Aug 18, 2026: Open-market sale of NKTR shares (Form 4, code S).
Jul 24, 2026: Grant or award of NKTR derivative securities (Form 4, code A).
Jun 17, 2026: Open-market sales of NKTR shares (2 lines, Form 4, code S).
Jun 16, 2026: Open-market sales of NKTR shares (2 lines, Form 4, code S).
May 19, 2026: Open-market sale of NKTR shares (Form 4, code S).

Other insiders filing for NEKTAR THERAPEUTICS (NKTR)

WHITFIELD ROY A, Director
GREER R SCOTT, Director
CHESS ROBERT, Director
Brainard Diana, Director
Ajer Jeffrey Robert, Director
Zalevsky Jonathan, Chief R&D Officer

How to read Form 4 transaction codes